Thierry Andr é, MD, on Interim Results from the Phase III Keynote-177 Study

The findings, presented at the 2020 ASCO Virtual Scientific Program, are the first to show benefit with pembrolizumab in patients with advanced colorectal cancer when used as a front-line therapy.

Source: CancerNetwork - June 1, 2020 Category: Cancer & Oncology Authors: Thierry Andr é, MD Source Type: news